Braden Michael Leonard, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 300,000 shares at $4.53 ($1.4M) on 2026-04-23, disclosed to the SEC on 2026-04-27.
Open-market sale of $1.4M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |
| ANTX | SELL | 2025-05-30 | $3.0M | — | Filing → |